Pilot Therapeutics Holdings Inc. (PLTT/PLTT.PK) Wrap Up:

Pilot Therapeutics Holdings, Inc., together with its wholly owned subsidiary, operates as a specialty pharmaceutical company. It develops therapeutic pharmaceutical products that are specifically designed to address dysfunctional lipid metabolism in chronic human diseases, such as asthma, coronary heart diseases, cancer, cystic acne, and rheumatoid arthritis. The company has strategic alliances with Wake Forest University School of Medicine, Johns Hopkins University School of Medicine, Clemson University, Bristol Myers Squibb, Quintiles Transnational Corporation and its affiliates, and National Institutes of Health. The company is based in Charleston, South Carolina.